Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Colorectal Neoplasms

  Free Subscription


1 Am J Surg
1 Ann Oncol
3 Ann Surg
1 BMC Cancer
1 Br J Cancer
3 Br J Surg
3 Cancer
1 Clin Cancer Res
1 Dig Dis
1 Eur J Gastroenterol Hepatol
5 Eur J Surg Oncol
2 Gastroenterology
1 Gut
2 Int J Cancer
1 Int J Colorectal Dis
1 Lancet Gastroenterol Hepatol
1 Lancet Oncol
2 Nat Rev Cancer
1 PLoS Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Surg

  1. KALTENMEIER C, Malik J, Yazdani H, Geller DA, et al
    Refusal of cancer-directed treatment by colon cancer patients: Risk factors and survival outcomes.
    Am J Surg. 2020 Apr 26. pii: S0002-9610(20)30226.
    PubMed         Abstract available

    Ann Oncol

  2. ARGILES G, Tabernero J, Labianca R, Hochhauser D, et al
    Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up.
    Ann Oncol. 2020 Jul 10. pii: S0923-7534(20)39932.

    Ann Surg

  3. O'LEARY MP, Choong KC, Thornblade LW, Fakih MG, et al
    Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic.
    Ann Surg. 2020;272:e98-e105.
    PubMed         Abstract available

  4. YUAN Z, Xu T, Cai J, Zhao Y, et al
    Development and Validation of an Image-based Deep Learning Algorithm for Detection of Synchronous Peritoneal Carcinomatosis in Colorectal Cancer.
    Ann Surg. 2020 Jul 16. doi: 10.1097/SLA.0000000000004229.
    PubMed         Abstract available

  5. OKUGAWA Y, Toiyama Y, Yamamoto A, Shigemori T, et al
    Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Ann Surg. 2020;272:342-351.
    PubMed         Abstract available

    BMC Cancer

  6. ANTONIOTTI C, Borelli B, Rossini D, Pietrantonio F, et al
    AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer.
    BMC Cancer. 2020;20:683.
    PubMed         Abstract available

    Br J Cancer

  7. CRAIG SG, Humphries MP, Alderdice M, Bingham V, et al
    Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia.
    Br J Cancer. 2020 Jul 20. pii: 10.1038/s41416-020-0985.
    PubMed         Abstract available

    Br J Surg

  8. WASMUTH HH, Faerden AE, Myklebust TA, Pfeffer F, et al
    Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg. 2020;107:121-130.
    PubMed         Abstract available

  9. VAN DER SLUIS FJ, Couwenberg AM, de Bock GH, Intven MPW, et al
    Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer.
    Br J Surg. 2020;107:131-139.
    PubMed         Abstract available

  10. MAEDA Y, Dunlop MG, Din FVN
    Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic.
    Br J Surg. 2020 Jul 23. doi: 10.1002/bjs.11798.


  11. WHEELER SB, O'Leary MC, Rhode J, Yang JY, et al
    Comparative cost-effectiveness of mailed fecal immunochemical testing (FIT)-based interventions for increasing colorectal cancer screening in the Medicaid population.
    Cancer. 2020 Jul 20. doi: 10.1002/cncr.32992.
    PubMed         Abstract available

  12. GREEN BB, Meenan RT
    Colorectal cancer screening: The costs and benefits of getting to 80% in every community.
    Cancer. 2020 Jul 20. doi: 10.1002/cncr.32990.

  13. SHAIB WL, Zakka KM, Jiang R, Yan M, et al
    Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
    Cancer. 2020 Jul 22. doi: 10.1002/cncr.33049.
    PubMed         Abstract available

    Clin Cancer Res

  14. KAWAZOE A, Kuboki Y, Shinozaki E, Hara H, et al
    Multicenter phase 1/2 Trial of napabucasin and pembrolizumab in patients with metastatic colorectal cancer (EPOC1503/SCOOP Trial).
    Clin Cancer Res. 2020 Jul 21. pii: 1078-0432.CCR-20-1803.
    PubMed         Abstract available

    Dig Dis

  15. BLACKETT JW, Verna EC, Lebwohl B
    Increased Prevalence of Colorectal Adenomas in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.
    Dig Dis. 2020;38:222-230.
    PubMed         Abstract available

    Eur J Gastroenterol Hepatol

  16. TOUCHEFEU Y, Duchalais E, Bruley des Varannes S, Alameddine J, et al
    Concomitant decrease of double-positive lymphocyte population CD4CD8alphaalpha and Faecalibacterium prausnitzii in patients with colorectal cancer.
    Eur J Gastroenterol Hepatol. 2020 Jul 14. doi: 10.1097/MEG.0000000000001842.
    PubMed         Abstract available

    Eur J Surg Oncol

  17. DULSKAS A, Pilvelis A
    Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
    Eur J Surg Oncol. 2020;46:105-107.
    PubMed         Abstract available

  18. IWAI T, Yamada T, Takahashi G, Takeda K, et al
    Circulating cell-free long DNA fragments predict post-hepatectomy recurrence of colorectal liver metastases.
    Eur J Surg Oncol. 2020;46:108-114.
    PubMed         Abstract available

  19. SHEN Z, Bu Z, Li A, Lu J, et al
    Multicenter study of surgical and oncologic outcomes of extra-levator versus conventional abdominoperineal excision for lower rectal cancer.
    Eur J Surg Oncol. 2020;46:115-122.
    PubMed         Abstract available

  20. SIDDIQUI J, Brown K, Zahid A, Young CJ, et al
    Current practices and barriers to referral for cytoreductive surgery and HIPEC among colorectal surgeons: A binational survey.
    Eur J Surg Oncol. 2020;46:166-172.
    PubMed         Abstract available

  21. TAPPER J, Arver S, Holm T, Bottai M, et al
    Acute primary testicular failure due to radiotherapy increases risk of severe postoperative adverse events in rectal cancer patients.
    Eur J Surg Oncol. 2020;46:98-104.
    PubMed         Abstract available


  22. PHILLIPS CJ, Schoen RE
    Screening For Colorectal Cancer in the Age of Simulation Models:A Historical Lens.
    Gastroenterology. 2020 Jul 16. pii: S0016-5085(20)34931.

  23. LEVIN TR, Jensen CD, Chawla NM, Sakoda LC, et al
    Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-based Colorectal Cancer Screening Program.
    Gastroenterology. 2020 Jul 15. pii: S0016-5085(20)34935.
    PubMed         Abstract available


  24. SIRINUKUNWATTANA K, Domingo E, Richman SD, Redmond KL, et al
    Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
    Gut. 2020 Jul 20. pii: gutjnl-2019-319866. doi: 10.1136/gutjnl-2019-319866.
    PubMed         Abstract available

    Int J Cancer

  25. LINDNER AU, Carberry S, Monsefi N, Barat A, et al
    Systems analysis of protein signatures predicting Cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild-type patient-derived xenografts models of metastatic colorectal cancer.
    Int J Cancer. 2020 Jul 23. doi: 10.1002/ijc.33226.
    PubMed         Abstract available

  26. AHADOVA A, Seppala TT, Engel C, Gallon R, et al
    The "unnatural" history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance.
    Int J Cancer. 2020 Jul 19. doi: 10.1002/ijc.33224.
    PubMed         Abstract available

    Int J Colorectal Dis

  27. HAN J, Lee KY, Kim NK, Min BS, et al
    Metachronous metastasis confined to isolated lymph node after curative treatment of colorectal cancer.
    Int J Colorectal Dis. 2020 Jul 21. pii: 10.1007/s00384-020-03695.
    PubMed         Abstract available

    Lancet Gastroenterol Hepatol

  28. RULLIER E, Vendrely V, Asselineau J, Rouanet P, et al
    Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Lancet Gastroenterol Hepatol. 2020;5:465-474.
    PubMed         Abstract available

    Lancet Oncol

  29. FOKAS E, Glynne-Jones R, Appelt A, Beets-Tan R, et al
    Outcome measures in multimodal rectal cancer trials.
    Lancet Oncol. 2020;21:e252-e264.
    PubMed         Abstract available

    Nat Rev Cancer

  30. DART A
    Leaving your mark.
    Nat Rev Cancer. 2020;20:260.

    Weighing up effects of extra chromosomes.
    Nat Rev Cancer. 2020;20:259.

    PLoS Med

  32. HEISSER T, Weigl K, Hoffmeister M, Brenner H, et al
    Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation.
    PLoS Med. 2020;17:e1003194.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.